Fibroblasts as Turned Agents in Cancer Progression
Cancers · 28.03.2023 · 15 (7) · 2014
DOI: 10.3390/cancers15072014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.03.2023. Verfasst von Robert Wieder. Beteiligte Einrichtung: Rutgers New Jersey Medical School and the Cancer Institute of New Jersey, Newark, NJ 07103, USA. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 594 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Differentiated epithelial cells reside in the homeostatic microenvironment of the native organ stroma. The stroma supports their normal function, their G0 differentiated state, and their expansion/contraction through the various stages of the life cycle and physiologic functions of the host. When malignant transformation begins, the microenvironment tries to suppress and eliminate the transformed cells, while cancer cells, in turn, try to resist these suppressive efforts. The tumor microenvironment encompasses a large variety of cell types recruited by the tumor to perform different functions, among which fibroblasts are the most abundant. The dynamics of the mutual relationship change as the sides undertake an epic battle for control of the other. In the process, the cancer “wounds” the microenvironment through a variety of mechanisms and attracts distant mesenchymal stem cells to change their function from one attempting to suppress the cancer, to one that supports its growth, survival, and metastasis. Analogous reciprocal interactions occur as well between disseminated cancer cells and the metastatic microenvironment, where the microenvironment attempts to eliminate cancer cells or suppress their proliferation. However, the altered microenvironmental cells acquire novel characteristics that support malignant progression. Investigations have attempted to use these traits as targets of novel therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers New Jersey Medical School and the Cancer Institute of New Jersey, Newark, NJ 07103, USA.
ORCID-Profile: Robert Wieder
Zitieren
APA
Wieder, R. (2023). Fibroblasts as Turned Agents in Cancer Progression. Cancers, 15(7), 2014. https://doi.org/10.3390/cancers15072014
Vancouver
Wieder R. Fibroblasts as Turned Agents in Cancer Progression. Cancers. 2023;15(7):2014. doi:10.3390/cancers15072014
BibTeX
@article{Wieder2023,
author = {Wieder, Robert},
title = {Fibroblasts as Turned Agents in Cancer Progression},
journal = {Cancers},
year = {2023},
volume = {15},
number = {7},
pages = {2014},
doi = {10.3390/cancers15072014}
}
EUVIMED